$8.25 +0.23 (2.87%) Advaxis Inc - NASDAQ

Dec. 2, 2016 | 04:00 PM

Quotes

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Last Trade: 8.25
Trade Time: Dec 02 04:00 PM Eastern Daylight Time
Change: +0.23 (2.87%)
Prev Close: 8.02
Open: 7.97
Bid: 8.24
Ask: 8.25
  1. Morning Call For Wednesday, Nov. 30

    TalkMarkets | Nov. 30, 2016 | 08:10AM EST
  2. Biotech Stock Advaxis: Outperformer In The Making

    TalkMarkets | Oct. 6, 2016 | 04:00AM EST
  3. Why Shares Of Advaxis Moved Higher On Tuesday

    Benzinga | Jan. 5, 2016 | 13:51PM EST
  4. Benzinga's Volume Movers

    Benzinga | Dec. 16, 2015 | 10:24AM EST
  5. ADVAXIS

    IBD | Oct. 6, 2015 | 17:35PM EST
  6. First Human Patient Treated in Phase 1b Study of Advaxis's ADXS-HER2 in HER2 Expressing Solid Tumors

    Benzinga | Sep. 28, 2015 | 08:05AM EST
  7. Phase 2 Study of Advaxis's Axalimogene Filolisbac (ADXS-HPV) in Cervical Cancer to be Presented at 2015 AGOS Annual Meeting

    Benzinga | Aug. 31, 2015 | 08:05AM EST
  8. Advaxis Announces Licensing Agreement With Knight Therapeutics and Raises $25 Million Through ...

    GuruFocus | Aug. 26, 2015 | 23:02PM EST
  9. Advaxis Offers '15 Half-Year Review, Outlook

    Benzinga | Jun. 25, 2015 | 06:31AM EST
  10. Advaxis Submits Special Protocol Assessment Request to FDA for ADXS-HPV Phase 3 Clinical Trial in Cervical Cancer

    Benzinga | Jun. 15, 2015 | 08:05AM EST
  11. US Stock Futures Edge Lower; Sears Q1 Loss Narrows

    Benzinga | Jun. 8, 2015 | 06:45AM EST
  12. Advaxis's Cancer Immunotherapy Delays Progression of HER2+ Canine Osteosarcoma

    Benzinga | Jun. 8, 2015 | 06:32AM EST
  13. Benzinga's Top Initiations

    Benzinga | May. 15, 2015 | 08:47AM EST
  14. Janney Capital Initiates Advaxis At Buy

    Benzinga | May. 15, 2015 | 07:15AM EST
  15. Aratana Therapeutics Comments on ADXS31-164 (AT-014) Study Data Presented During Poster Session at the American Association for Cancer Research (AACR) Annual Meeting 2015

    Benzinga | Apr. 27, 2015 | 08:03AM EST
Trading Center